{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"10.6","value":"51.4"},{"groupId":"OG001","spread":"9.9","value":"55.0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"27"},{"groupId":"OG001","value":"27"}],"units":"Participants"}],"description":"Metacognition index (MI) was measured by BRIEF test. Assessments within the time window, from eligible and evaluable patients are reported. If the patient had disease progression, only the assessments before progression date were reported. The MI is a standard T- score, and it ranges from 0 to 100. The higher score reported suggests a higher level of dysfunction.","dispersionType":"Standard Deviation","groups":[{"description":"Includes eligible patients 3-7 years of age without anaplastic histology or evidence of disseminated or ERD based on central review and randomized to one of the LDCSI arms (Treatment Arms I or II) and with a post-treatment TSH value.","id":"OG000","title":"Low-dose Craniospinal Radiation (LDSCI)"},{"description":"Includes eligible patients 3-7 years of age without anaplastic histology or evidence of disseminated or ERD based on central review and randomized to one of the SDCSI arms (Treatment Arms III or IV) and with a post-treatment TSH value.","id":"OG001","title":"Standard-dose Craniospinal Radiation (SDCSI)"}],"paramType":"MEAN","populationDescription":"Only eligible \\& evaluable patients 3-7 years of age with MI values within time window were included.","reportingStatus":"POSTED","timeFrame":"27-48 months post diagnosis","title":"Post-treatment Metacognition Index (MI) on the Behavior Rating Inventory of Executive Function (BRIEF) by CSI Group Within Time Window 2 (27-48 Months Post Diagnosis)","type":"SECONDARY","unitOfMeasure":"T-score"}